INTRODUCTION
Neutrophils are the most important circulating phagocytic cells and therefore, any alteration of their function may increase the susceptibility to infection, especially during the neonatal period when the defense against infection is dependent mainly on the innate immunity. [1] [2] [3] [4] [5] However, little is known about neutrophil functional activity in neonates born to mothers with gestational diabetes. Although, reduced cell-mediated immunity and lower chemotactic activity of cord blood neutrophils from infants of diabetic mothers has been reported, [6] [7] [8] [9] other important aspects of neutrophil function such as the oxidative and metabolic activity of phagocytizing neutrophils were not investigated. Furthermore, no study has assessed the neutrophil functional activity in neonates born to gestational diabetic mothers (GDM) who received insulin and those who did not.
We hypothesized, that neutrophil function in neonates born to gestational diabetic mothers depends on whether the mother receives insulin for control of the hyperglycemia. The rationale of our hypotheses is based on studies showing differences in cellular immunity of neonates born to mothers with different types of diabetes 8 and an association between the type of diabetes mellitus in adults and their neutrophil functional activity. 10 This study presents the chemotaxis, random motility, and chemiluminescence of cord blood neutrophils from term neonates born to mothers with gestational diabetes. Differences in the treatment pattern of gestational diabetics and the occurrence of hypoglycemia in their neonates after birth were taken into consideration.
MATERIALS AND METHODS
To test the hypotheses, we designed a case-control study. The convenience sample of 20 term neonates born to mothers with gestational diabetes mellitus were defined as the cases. Based on the modified White's classification of diabetes in pregnancy, 11 the cases were divided into two groups: 12 neonates born to gestational diabetic mothers who received no insulin (GDM-NI), and eight to gestational diabetic mothers who received insulin (GDM). Normal glucose levels during the pregnancy and no morbidity in the mother as well as normoglycemia and absence of complications in the neonate was a requirement for assembling the control group of healthy term infants (n ¼ 10). None of these mothers had a history of preconceptual diabetes or prolonged labor. 12 Healthy adult volunteers (n ¼ 10) were also utilized as controls. Neonatal hypoglycemia was defined as a serum glucose level less than 40 mg/dl (2.2 mmol/l) in the first 24 hours of life. 13 We collected additional information regarding the symptoms associated with hypoglycemia such as: thermoregulatory problems, tremors, seizure activity, jitteriness, irritability, respiratory distress, apnea, and cyanosis, hypotonia, lethargy, listlessness and poor feeding. 14 The study was approved by the Institutional Research and Publications Review Committee in human subjects. Informed comment for obtaining cord blood was not required by the Committee. Neonatal cord blood and adult peripheral venous blood was obtained for neutrophil isolation and testing of neutrophil random motility, chemotaxis and chemiluminescence.
Neutrophil Isolation
Neutrophils were isolated from the heparinized blood samples by dextran sedimentation and Ficoll gradient centrifugation. 15 Red blood cells were removed by hypotonic lysis. The cells were suspended in Hanks' balanced salt solution (HBSS) without Ca 2 þ , Mg 2 þ and phenol red. After separation, the cell suspension contained 85% neutrophils and trypan blue dye showed >95% neutrophil viability.
Measurement of Chemotaxis and Random Motility
The neutrophil concentrations were adjusted to 2.0 Â 10 6 cells/ml, with 2% bovine serum albumin (BSA). Chemotaxis and random motility were quantified using modified Boyden microchemotactic chambers (Neuro-Probe, Inc., Bethesda, MD). The migration through 5-mm pore cellulose nitrate filters (Millipore Corp., Bedford, MA) 16 was measured in response to pooled human adult serum activated by zymosan (Sigma Laboratories, St Louis, MO) (chemotaxis) or tissue culture medium 199 (Gibco Laboratories, Grand Island, NY) (random motility) in the lower wells. The chambers were incubated (2 hours, 371C) and then analyzed by an investigator blinded to the sample source. Chemotaxis and random motility of neutrophils were expressed as the mean depth (mm) at which the leading front of neutrophils was in focus using the Â 40 objective. Values represent the mean of five randomly chosen microscopic fields in each filter. Using this assay, the coefficient of variation between assays for healthy adult neutrophils was <10%.
Measurement of Chemiluminescence
The neutrophil concentrations were adjusted to a concentration of 1.0 Â 10 6 cells/ml. Luminol-enhanced chemiluminescence (Sigma Diagnostics, St Louis, MO), a measure of energy released as photons during oxidative metabolism, [17] [18] [19] was measured using a liquid scintillation system (Beckman model LS-230, Beckman Instruments, Inc., Fullerton, CA). Latex particles (0.8 mm in diameter; Seragon Diagnostics, Indianapolis, IN) functioned as stimulants for the phagocytosis and oxidative burst. Peak levels in counts per minute (cpm Â l0
3 ) for 1.0 Â 10 6 neutrophils were quantified in duplicate.
Statistical Analysis
The measurements of neutrophil functional activity are presented as mean and standard deviation (SD). To compare continuous variables, analysis of variance followed by Tukey's test was used. We compared categorical data by w 2 test. Additionally, we assessed the correlation between the neutrophil function measurements in the cases and controls by using the Pearson's correlation coefficient (r). A two-sided p-value less than 0.05 was considered statistically significant.
RESULTS
The neonatal cases and controls were comparable by gestational age (GA), birth weight (BW), number of large for gestational age (LGA) infants, and cesarean section (CS) births (Table 1 ). All cases and controls were delivered following normal labor. There was no significant difference between the numbers of infants with severe hypoglycemic events after birth in the two groups of neonates born to gestational diabetic mothers ( Table 1 ). The neonates diagnosed with hypoglycemia were clinically asymptomatic. None of the infants among the cases and controls had Apgar scores less than 8 at 1 and 5 minutes, or clinical evidence of infection before discharge from the hospital. Neutrophil chemotaxis, random motility and chemiluminescence in the cord blood of neonates were lower than in adults (Table 2) . We found decreased neutrophil functional activity in neonates born to both types of gestational diabetic mothers as compared to the neonatal controls. The tested parameters of neutrophil functional activity in neonates born to mothers with gestational diabetes were tightly correlated between each other (Figure 1 ). However, in the healthy neonatal and adult controls, the same tested parameters did not demonstrate any significant association (data not presented).
The cord blood neutrophil chemiluminescence, chemotaxis and random motility of neonates who experienced hypoglycemia after birth was slightly but not significantly lower than in neonates who remained normoglycemic (140.8±6.2 vs 142.4±7.5, 52.3±1.2 vs 53.3±2.4, and 40.8±2.1 vs 43.0±5.1, respectively).
DISCUSSION
There is evidence that both types of gestational diabetes has a strong genetic component and is characterized by insulin deficiency and/or insulin resistance that requires dietary measures and possibly insulin in order to maintain normoglycemia throughout the pregnancy. 20, 21 Extrapolating from the studies of neutrophil functional activity in the blood of adult diabetics, [22] [23] [24] we can assume that the impairment of the neutrophil function in neonates born to mothers with gestational diabetes is associated with the fetal hyperglycemia and hyperinsulinemia that results from the maternal hyperglycemia. 25 The finding that elevated glucose levels can cause peroxidation of membrane lipids in human red blood cells, 26, 27 becomes especially significant for neonates whose erythrocytes demonstrate a high susceptibility to oxidative damage due to altered lipid composition and organization across the membranous bilayer. 28 In neutrophils too, metabolic abnormalities have been shown to alter protein synthesis, microtubular structure, and cell membrane depolarization. 23, 24, 29, 30 In the present study, for the first time we demonstrated reduced cord blood neutrophil motility and phagocytic activity in term neonates born to mothers with both types of gestational diabetes. Maternal insulin therapy per se, did not influence the cord blood neutrophil functional activity. Conceivably, the risk of an enhanced maternal glucose concentration, increased flux of glucose from the mother to the fetus, and the development of neonatal hypoglycemia is comparable for the neonates born to insulin receiving and noninsulin receiving gestational diabetic mothers. Absence of variation in the number of hypoglycemic events in the neonates born to both types of gestational diabetic mothers confirms this assumption.
Factors such as gender and mode of delivery may impact neutrophil functional activity in neonates. However, the reports on this subject are contentious. [31] [32] [33] We found that stratification analysis by gender and mode of delivery did not meaningfully change the association between neutrophil functional activity and maternal diabetes (data not presented).
We conclude that gestational diabetes independent of insulin therapy is a risk factor for the impairment of the neutrophil motility and postphagocytic bactericidal capacity in term neonates. However, the immune system's defense capability may be maintained by the development of a strong correlation between the reduced activities of the neutrophil functional parameters. These new findings not only add to our knowledge regarding innate immune competence and clinical problems experienced by neonates with abnormal metabolic state due to gestational diabetes, but can also be useful for improvement of the management and outcome of diabetic pregnancies.
